ArcBest (ARCB) Tops Q4 EPS by 14c

ArcBest (NASDAQ: ARCB) reported Q4 EPS of $0.56, $0.14 better than the analyst estimate of $0.42. Revenue for the quarter came in at $717.4 million versus the consensus estimate of $721.1 million.

For earnings history and earnings-related data on ArcBest (ARCB) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Immucell Corp (ICCC) Reports Q2 EPS of $0.20
• Eton Pharmaceuticals Inc. (ETON) Tops Q2 EPS by 28c, Raises Guidance